Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.600
-0.030 (-1.14%)
Mar 24, 2026, 12:05 PM EDT - Market open
Aytu BioPharma Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$9.33
Upside
+258.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $13 → $13 | Strong Buy | Maintains | $13 → $13 | +399.98% | Dec 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +169.22% | Sep 25, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +380.75% | Sep 25, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +207.68% | Jul 1, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +361.52% | Jun 30, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +92.30% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +669.20% | May 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $120 | Strong Buy | Maintains | $220 → $120 | +4,515.21% | Jul 21, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $220 → $100 | Buy | Maintains | $220 → $100 | +3,746.01% | May 17, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $480 → $220 | Strong Buy | Maintains | $480 → $220 | +8,361.21% | Apr 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $220 | Buy | Initiates | $220 | +8,361.21% | Mar 30, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $600 | Strong Buy | Initiates | $600 | +22,976.04% | May 29, 2020 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates $2,000 | Buy | Initiates | $2,000 | +76,820.12% | Oct 22, 2018 |